{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T08:11:57Z","timestamp":1769760717948,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2010-0005370"],"award-info":[{"award-number":["2010-0005370"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.jpba.2011.07.019","type":"journal-article","created":{"date-parts":[[2011,7,26]],"date-time":"2011-07-26T02:10:29Z","timestamp":1311646229000},"page":"771-777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Simple and accurate quantitative analysis of ten antiepileptic drugs in human plasma by liquid chromatography\/tandem mass spectrometry"],"prefix":"10.1016","volume":"56","author":[{"given":"Kwon-Bok","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Ah.","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Kyung","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Gook","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2011.07.019_bib0005","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.291.5.605","article-title":"The new antiepileptic drugs","volume":"291","author":"LaRoche","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jpba.2011.07.019_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1684\/epd.2009.0238","volume":"11","author":"Mula","year":"2009","journal-title":"Epilep. Disord."},{"key":"10.1016\/j.jpba.2011.07.019_bib0015","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jchromb.2005.09.019","article-title":"Liquid chromatography\u2013electrospray mass spectrometry determination of carbamazepine, oxcarbazepine and eight of their metabolites in human plasma","volume":"828","author":"Breton","year":"2005","journal-title":"J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2011.07.019_bib0020","first-page":"S12","article-title":"Emerging antiepileptic drugs","volume":"43","author":"Fisher","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jpba.2011.07.019_bib0025","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jchromb.2005.09.009","article-title":"Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy","volume":"828","author":"Contin","year":"2005","journal-title":"J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2011.07.019_bib0030","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jchromb.2009.11.039","article-title":"HPLC\u2013UV analysis of rufinamide, zonisamide, lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in deproteinized plasma of patients with epilepsy","volume":"878","author":"Contin","year":"2010","journal-title":"J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2011.07.019_bib0035","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1570-0232(02)00664-5","article-title":"Liquid chromatographic determination of oxcarbazepine and its metabolites in plasma of epileptic patients after solid-phase extraction","volume":"783","author":"Mandrioli","year":"2003","journal-title":"J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2011.07.019_bib0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jchromb.2007.06.023","article-title":"Robust isocratic high performance liquid chromatographic method for simultaneous determination of seven antiepileptic drugs including lamotrigine, oxcarbazepine and zonisamide in serum after solid-phase extraction","volume":"857","author":"Vermeij","year":"2007","journal-title":"J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2011.07.019_bib0045","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jpba.2006.02.044","article-title":"Simultaneous determination of zonisamide, carbamazepine and carbamazepine-10,11-epoxide in infant serum by high-performance liquid chromatography","volume":"41","author":"Yoshida","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2011.07.019_bib0050","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0731-7085(03)00525-9","article-title":"Simultaneous separation and quantitation of four antiepileptic drugs\u2014a study with potential for use in patient drug level monitoring","volume":"34","author":"Manoj Babu","year":"2004","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2011.07.019_bib0055","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/00007691-200008000-00016","article-title":"Comparison of topiramate concentrations in plasma and serum by fluorescence polarization immunoassay","volume":"22","author":"Berry","year":"2000","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2011.07.019_bib0060","first-page":"87","article-title":"Restricted-access media high pressure liquid chromatography vs fluorescence polarization immunoassay for analysis of carbamazepine in human plasma","volume":"23","author":"Ma","year":"2002","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jpba.2011.07.019_bib0065","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00007691-199712000-00006","article-title":"Is saliva suitable for therapeutic monitoring of anticonvulsants in children: an evaluation in the routine clinical setting","volume":"19","author":"Gorodischer","year":"1997","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2011.07.019_bib0070","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/00007691-199412000-00013","article-title":"Comparison of phenytoin and carbamazepine serum concentrations measured by high-performance liquid chromatography, the standard TDx assay, the enzyme multiplied immunoassay technique, and a new patient-side immunoassay cartridge system","volume":"16","author":"Rambeck","year":"1994","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2011.07.019_bib0075","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/FTD.0b013e3181678ecb","article-title":"High-speed simultaneous determination of nine antiepileptic drugs using liquid chromatography\u2013mass spectrometry","volume":"30","author":"Subramanian","year":"2008","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2011.07.019_bib0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0009-2797(02)00057-1","article-title":"Mechanisms of idiosyncratic drug reactions: the case of felbamate","volume":"142","author":"Dieckhaus","year":"2002","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.jpba.2011.07.019_bib0085","series-title":"US FDA Guidance for Industry\/Bioanalytical Method Validation","author":"United States Food and Drug Administration","year":"2001"},{"key":"10.1016\/j.jpba.2011.07.019_bib0090","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC\u2013MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2011.07.019_bib0095","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/rcm.2821","article-title":"The accuracy of oxcarbazepine (OXC) quantification by a liquid chromatography\/tandem mass spectrometry method is influenced by the ion source fragmentation of its metabolite trans-diol-carbazepine (DHD)","volume":"21","author":"Corso","year":"2007","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2011.07.019_bib0100","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs\u2014best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring. ILAE Commission on Therapeutic Strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708511003918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708511003918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T08:47:36Z","timestamp":1759999656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708511003918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0731708511003918"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2011.07.019","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simple and accurate quantitative analysis of ten antiepileptic drugs in human plasma by liquid chromatography\/tandem mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2011.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}